CN102512592A - Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same - Google Patents

Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same Download PDF

Info

Publication number
CN102512592A
CN102512592A CN2011104235182A CN201110423518A CN102512592A CN 102512592 A CN102512592 A CN 102512592A CN 2011104235182 A CN2011104235182 A CN 2011104235182A CN 201110423518 A CN201110423518 A CN 201110423518A CN 102512592 A CN102512592 A CN 102512592A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
traditional chinese
idiopathic thrombocytopenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011104235182A
Other languages
Chinese (zh)
Other versions
CN102512592B (en
Inventor
刘珂
李梦周
潘丽娟
阮林海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of Henan University of Science and Technology
Original Assignee
First Affiliated Hospital of Henan University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of Henan University of Science and Technology filed Critical First Affiliated Hospital of Henan University of Science and Technology
Priority to CN201110423518.2A priority Critical patent/CN102512592B/en
Publication of CN102512592A publication Critical patent/CN102512592A/en
Application granted granted Critical
Publication of CN102512592B publication Critical patent/CN102512592B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating hematopathy, particularly to a traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and a preparation method for the same, wherein the traditional Chinese medicine capsule is composed of traditional Chinese medicine raw materials in the following parts by weight: 30-50 parts of cornu bubali powder, 2-4 parts of tripterygium wilfordii, 12-30 parts of indigo naturalis, 30-50 parts of scutellaria baicalensis, 30-50 parts of coptis chinensis, 30-50 parts of isatis root, 30-50 parts of callicarpa bodinieri, 30-50 parts of astragalus mongholicus, 20-45 parts of donkey-hide gelatin, 30-50 parts of angelica sinensis, 30-50 parts of caulis spatholobi, 30-50 parts of polygonum multiflorum, 30-50 parts of rhizoma polygonati, 30-45 parts of radix rehmanniae preparata, 30-50 parts of agrimonia pilosa, 30-50 parts of moutan bark and 30-50 parts of liquorice. The preparation method comprises the following steps of: crushing traditional Chinese medicine raw materials composed by weight; mixing the traditional Chinese medicine raw materials with the refined honey and then drying; and crushing into powder and then filling in capsules.

Description

Chinese medicinal capsule of treatment idiopathic thrombocytopenic purpura and preparation method thereof
Technical field
The present invention relates to the hemopathic medicine of a kind of treatment, particularly a kind of method for preparing of treating the Chinese medicinal capsule of idiopathic thrombocytopenic purpura.
Background technology
Idiopathic thrombocytopenic purpura is a kind of immune-mediated thrombocytopenia syndrome; With mucocutaneous, visceral hemorrhage and peripheral blood thrombocytopenia is characteristic; Bone marrow megakaryocyte quantity increases, normal or minimizing; Companion's dysmaturity, treatment that at present should disease is main with experience, does not still have generally acknowledged Therapeutic Principle.Though glucocorticoid is the choice drug of idiopathic thrombocytopenic purpura; But decrement or drug withdrawal are easy to recurrence; And the long-term treatment adverse reaction rate is high, and the effect of immunosuppressant toxic and side effects is big, can not be lasting and the treatment of intravenous applications gamma globulin is many.The Chinese medicine primary disease belongs to " mass formed by blood stasis ", " sending out speckle ", " asthenia " category.The overall side effect of western medical treatment is big, and relapse rate is high, and mortality rate is about about 1%.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicinal capsule of treating idiopathic thrombocytopenic purpura and preparation method thereof, it has heat-clearing and toxic substances removing, cooling blood for hemostasis, liver and kidney tonifying, invigorating the spleen and benefiting QI, effects such as blood circulation promoting and blood stasis dispelling.Effectively promote platelet counts.
The object of the invention can adopt following technical scheme to come real the sight: the Chinese medicinal capsule of described treatment idiopathic thrombocytopenic purpura, form by following parts by weight of Chinese traditional medicine raw material:
Cornu Bubali powder 30-50 part, Radix Tripterygii Wilfordii 2-4 part, Indigo Naturalis 12-30 part, Radix Scutellariae 30-50 part, Rhizoma Coptidis 30-50 part; Radix Isatidis 30-50 part, Folium Callicarpae Formosanae 30-50 part, Radix Astragali 30-50 part, Colla Corii Asini 20-45 part; Radix Angelicae Sinensis 30-50 part, Caulis Spatholobi 30-50 part, Radix Polygoni Multiflori 30-50 part, Rhizoma Polygonati 30-50 part; Radix Rehmanniae Preparata 30-45 part, Herba Agrimoniae 30-50 part, Cortex Moutan 30-50 part, Radix Glycyrrhizae 30-50 part.
The capsule preparation method thereof of said Chinese medicine: above-mentioned raw material of Chinese medicine is pulverized, mixed the back oven dry with the good Mel of refining then, be ground into Powdered incapsulating after the oven dry again.
Chinese medicine is learned to study and is shown in the important source material of the present invention, wherein:
Cornu Bubali powder: bitter in the mouth, cold in nature, have heat-clearing and toxic substances removing, the effect of cooling blood for hemostasis;
Radix Tripterygii Wilfordii: bitter in the mouth, cold in nature, have expelling wind and removing dampness, effects such as dispelling toxins and dredging collaterals;
Indigo Naturalis: bitter in the mouth, cold in nature, nontoxic, have the effect of heat clearing away, removing heat from blood, detoxifcation;
Radix Scutellariae: bitter in the mouth, cold in nature, have heat clearing and damp drying, the effect of hemostasis;
Rhizoma Coptidis: bitter in the mouth, cold in nature, have the effect of eliminating fire and detoxication;
Radix Isatidis: bitter in the mouth, cold in nature, the effect of heat-clearing and toxic substances removing, blood cooling and ecchymoses removing;
Folium Callicarpae Formosanae: bitter in the mouth, cold in nature, puckery, cool, have heat-clearing and toxic substances removing, the effect of cooling blood for hemostasis;
The Radix Astragali: nature and flavor are sweet, and tepor has the effect of qi-supplementing, blood-engendering;
Colla Corii Asini: nature and flavor are sweet, have enrich blood, the effect of removing heat from blood, lung moistening, YIN nourishing;
Radix Angelicae Sinensis: sweet in the mouth is hot, and tepor has the effect of tonifying blood and arresting bleeding;
Caulis Spatholobi: nature and flavor, sweet, hardship, tepor has tonifying blood and arresting bleeding, the effect of collateral dredging;
Radix Polygoni Multiflori: nature and flavor, sweet puckery, tepor has invigorating the liver and kidney, the effect of benefiting essence-blood;
Rhizoma Polygonati: sweet in the mouth, property is flat, has supplementing QI and nourishing YIN, the effect of mediation the five internal organs;
Radix Rehmanniae Preparata: nature and flavor are sweet, and tepor has the effect of the YIN nourishing of enriching blood;
Herba Agrimoniae: nature and flavor, bitter cool, have the effect of cooling blood for hemostasis;
Cortex Moutan: cold in nature, bitter in the mouth has the effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis;
Radix Glycyrrhizae: nature and flavor are sweet flat, have invigorating the spleen and replenishing QI, the effect of heat-clearing and toxic substances removing, mediation principal agent.
The present invention forms through long-term clinical practice research; Main pathogenesis according to idiopathic thrombocytopenic purpura is " heat, empty, the stasis of blood " three kinds, and the medicine of employing has clearing away heat and cooling blood hemostasis, boosting qi and nourishing yin; Blood circulation promoting and blood stasis dispelling; Liver and kidney tonifying, invigorating the spleen and benefiting QI promotes platelet, hemostatic purpose thereby reach.
Medicine of the present invention was used to treat idiopathic thrombocytopenic purpura 350 examples in 5 years, and total effective rate reaches about 95%, and the treatment criterion of therapeutical effect is according to " hematopathy diagnosis and the treatment standard " third edition one book of Zhang Zhinan chief editor.Most patients use onset in back two days, stopped bleeding.Shang Weijian has dead patient to take place.
The specific embodiment
Embodiment 1:Described Chinese medicinal capsule is made up of following raw material of Chinese medicine by weight: 30 parts of Cornu Bubali powders, 2 parts of Radix Tripterygii Wilfordiis, 16 parts of Indigo Naturaliss, 30 parts of Radix Scutellariaes, 30 parts of Rhizoma Coptidis; 35 parts of Radix Isatidis, 30 parts of Folium Callicarpae Formosanaes, 30 parts of the Radixs Astragali, 20 parts in Colla Corii Asini; 30 parts of Radix Angelicae Sinensis, 30 parts of Caulis Spatholobis, 30 parts of Radix Polygoni Multiflori, 30 parts of Rhizoma Polygonatis; 30 parts in Radix Rehmanniae Preparata, 30 parts of Herba Agrimoniaes, 30 parts of Cortex Moutans, 30 parts in Radix Glycyrrhizae.
Method for preparing: above-mentioned raw material of Chinese medicine is pulverized, mixed the back oven dry with the good Mel of refining then, be ground into Powdered incapsulating after the oven dry again.
Embodiment 2:Described Chinese medicinal capsule is made up of following raw material of Chinese medicine by weight: 40 parts of Cornu Bubali powders, 3 parts of Radix Tripterygii Wilfordiis, 20 parts of Indigo Naturaliss, 40 parts of Radix Scutellariaes, 40 parts of Rhizoma Coptidis; 40 parts of Radix Isatidis, 40 parts of Folium Callicarpae Formosanaes, 40 parts of the Radixs Astragali, 30 parts in Colla Corii Asini; 40 parts of Radix Angelicae Sinensis, 40 parts of Caulis Spatholobis, 40 parts of Radix Polygoni Multiflori, 40 parts of Rhizoma Polygonatis; 40 parts in Radix Rehmanniae Preparata, 40 parts of Herba Agrimoniaes, 40 parts of Cortex Moutans, 40 parts in Radix Glycyrrhizae.
Method for preparing: above-mentioned raw material of Chinese medicine is pulverized, mixed the back oven dry with the good Mel of refining then, be ground into Powdered incapsulating after the oven dry again.
Embodiment 3:Described Chinese medicinal capsule is made up of following raw material of Chinese medicine by weight: 50 parts of Cornu Bubali powders, 4 parts of Radix Tripterygii Wilfordiis, 30 parts of Indigo Naturaliss, 50 parts of Radix Scutellariaes, 50 parts of Rhizoma Coptidis; 50 parts of Radix Isatidis, 50 parts of Folium Callicarpae Formosanaes, 50 parts of the Radixs Astragali, 45 parts in Colla Corii Asini; 50 parts of Radix Angelicae Sinensis, 50 parts of Caulis Spatholobis, 50 parts of Radix Polygoni Multiflori, 50 parts of Rhizoma Polygonatis; 45 parts in Radix Rehmanniae Preparata, 50 parts of Herba Agrimoniaes, 50 parts of Cortex Moutans, 45 parts in Radix Glycyrrhizae.
Method for preparing: above-mentioned raw material of Chinese medicine is pulverized, mixed the back oven dry with the good Mel of refining then, be ground into Powdered incapsulating after the oven dry again.

Claims (5)

1. a Chinese medicinal capsule of treating idiopathic thrombocytopenic purpura is characterized in that being made up of following parts by weight of Chinese traditional medicine raw material: Cornu Bubali powder 30-50 part, Radix Tripterygii Wilfordii 2-4 part, Indigo Naturalis 12-30 part, Radix Scutellariae 30-50 part; Rhizoma Coptidis 30-50 part, Radix Isatidis 30-50 part, Folium Callicarpae Formosanae 30-50 part, Radix Astragali 30-50 part, Colla Corii Asini 20-45 part; Radix Angelicae Sinensis 30-50 part, Caulis Spatholobi 30-50 part, Radix Polygoni Multiflori 30-50 part, Rhizoma Polygonati 30-50 part; Radix Rehmanniae Preparata 30-45 part, Herba Agrimoniae 30-50 part, Cortex Moutan 30-50 part, Radix Glycyrrhizae 30-50 part.
2. the Chinese medicinal capsule of treatment idiopathic thrombocytopenic purpura according to claim 1 is characterized in that being made up of following parts by weight of Chinese traditional medicine raw material: 30 parts of Cornu Bubali powders, 2 parts of Radix Tripterygii Wilfordiis, 16 parts of Indigo Naturaliss, 30 parts of Radix Scutellariaes; 30 parts of Rhizoma Coptidis, 35 parts of Radix Isatidis, 30 parts of Folium Callicarpae Formosanaes, 30 parts of the Radixs Astragali, 20 parts in Colla Corii Asini; 30 parts of Radix Angelicae Sinensis, 30 parts of Caulis Spatholobis, 30 parts of Radix Polygoni Multiflori, 30 parts of Rhizoma Polygonatis; 30 parts in Radix Rehmanniae Preparata, 30 parts of Herba Agrimoniaes, 30 parts of Cortex Moutans, 30 parts in Radix Glycyrrhizae.
3. the Chinese medicinal capsule of treatment idiopathic thrombocytopenic purpura according to claim 1 is characterized in that being made up of following parts by weight of Chinese traditional medicine raw material: 40 parts of Cornu Bubali powders, 3 parts of Radix Tripterygii Wilfordiis, 20 parts of Indigo Naturaliss, 40 parts of Radix Scutellariaes; 40 parts of Rhizoma Coptidis, 40 parts of Radix Isatidis, 40 parts of Folium Callicarpae Formosanaes, 40 parts of the Radixs Astragali, 30 parts in Colla Corii Asini; 40 parts of Radix Angelicae Sinensis, 40 parts of Caulis Spatholobis, 40 parts of Radix Polygoni Multiflori, 40 parts of Rhizoma Polygonatis; 40 parts in Radix Rehmanniae Preparata, 40 parts of Herba Agrimoniaes, 40 parts of Cortex Moutans, 40 parts in Radix Glycyrrhizae.
4. treatment specificity platelet according to claim 1 reduces the Chinese medicinal capsule of purpura, it is characterized in that being made up of following parts by weight of Chinese traditional medicine raw material: 50 parts of Cornu Bubali powders, 4 parts of Radix Tripterygii Wilfordiis, 30 parts of Indigo Naturaliss, 50 parts of Radix Scutellariaes; 50 parts of Rhizoma Coptidis, 50 parts of Radix Isatidis, 50 parts of Folium Callicarpae Formosanaes, 50 parts of the Radixs Astragali, 45 parts in Colla Corii Asini; 50 parts of Radix Angelicae Sinensis, 50 parts of Caulis Spatholobis, 50 parts of Radix Polygoni Multiflori, 50 parts of Rhizoma Polygonatis; 45 parts in Radix Rehmanniae Preparata, 50 parts of Herba Agrimoniaes, 50 parts of Cortex Moutans, 45 parts in Radix Glycyrrhizae.
5. power such as profit require 1 or 2 or the method for preparing of the Chinese medicinal capsule of 3 or 4 said treatment idiopathic thrombocytopenic purpuras; It is characterized in that: will be according to the parts by weight of Chinese traditional medicine raw material pulverizing; Mix the back oven dry with the good Mel of refining then, be ground into Powdered incapsulating after the oven dry again.
CN201110423518.2A 2011-12-16 2011-12-16 Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same Expired - Fee Related CN102512592B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110423518.2A CN102512592B (en) 2011-12-16 2011-12-16 Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110423518.2A CN102512592B (en) 2011-12-16 2011-12-16 Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same

Publications (2)

Publication Number Publication Date
CN102512592A true CN102512592A (en) 2012-06-27
CN102512592B CN102512592B (en) 2014-12-03

Family

ID=46283844

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110423518.2A Expired - Fee Related CN102512592B (en) 2011-12-16 2011-12-16 Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same

Country Status (1)

Country Link
CN (1) CN102512592B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772685A (en) * 2012-07-16 2012-11-14 梁艳龙 Traditional Chinese medicinal preparation for treating aplastic anemia
CN103316243A (en) * 2013-06-26 2013-09-25 张秀兰 Drug for treating thrombocytopenic purpura and preparation method thereof
CN103690692A (en) * 2013-11-29 2014-04-02 周晨 Traditional Chinese medicine formula for treating purpura
CN105055637A (en) * 2015-08-28 2015-11-18 蒋玉群 Traditional Chinese medicine composition for treating thrombocytopenic purpura
CN105663674A (en) * 2016-01-27 2016-06-15 济南正骐生物科技有限公司 Traditional Chinese medicine for treating thrombocytopenic purpura and preparation method of traditional Chinese medicine

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
冯晓纯: "王烈教授对小儿紫癜的证治经验", 《吉林中医药》 *
张之南等: "《血液病诊断及疗效标准》", 31 August 2007, 科学出版社 *
张永锋等: "归蓉补血片治疗特发性血小板减少性紫癜42例", 《安徽中医医院学报》 *
徐雯雯: "紫茜胶囊治疗慢性原发性血小板减少性紫癜的临床观察", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 *
无: "止血养板汤治疗慢性特发性血小板减少性紫癜", 《江西中医药》 *
王益平等: "名中医治疗血小板减少性紫癜的经验及思路分析", 《现代中医药》 *
郭子光: "寒温结合治疗疑难病症", 《新中医》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772685A (en) * 2012-07-16 2012-11-14 梁艳龙 Traditional Chinese medicinal preparation for treating aplastic anemia
CN102772685B (en) * 2012-07-16 2014-07-02 梁艳龙 Traditional Chinese medicinal preparation for treating aplastic anemia
CN103316243A (en) * 2013-06-26 2013-09-25 张秀兰 Drug for treating thrombocytopenic purpura and preparation method thereof
CN103690692A (en) * 2013-11-29 2014-04-02 周晨 Traditional Chinese medicine formula for treating purpura
CN105055637A (en) * 2015-08-28 2015-11-18 蒋玉群 Traditional Chinese medicine composition for treating thrombocytopenic purpura
CN105663674A (en) * 2016-01-27 2016-06-15 济南正骐生物科技有限公司 Traditional Chinese medicine for treating thrombocytopenic purpura and preparation method of traditional Chinese medicine

Also Published As

Publication number Publication date
CN102512592B (en) 2014-12-03

Similar Documents

Publication Publication Date Title
CN103768537B (en) Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris
CN103784820A (en) Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease
CN103341004A (en) Chinese medicine composition for treating delayed menstrual cycle
CN102512592B (en) Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same
CN103705866A (en) Traditional Chinese medicine composition for treating hypomenorrhea
CN102526691A (en) External application plaster for treating dysmenorrhea
CN103623218A (en) Body-strengthening spirit-nourishing traditional Chinese medicine composition
CN103330805A (en) Traditional Chinese medicine composition for treating menorrhagia
CN100500131C (en) Granular powder for strengthening spleen and nourishing stomach and preparing method
CN103720996A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN103550687A (en) Traditional Chinese medicine (TCM) composition for treating deficiency of liver-yin and kidney-yin
CN102988616B (en) Chinese medicinal composition for treating anemia
CN105268006A (en) Natural Chinese herbal medicine nursing blended incense and preparation method thereof
CN104173565A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN102205059A (en) Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof
CN104888131A (en) Traditional Chinese medicine composition for treatment of insomnia
CN103211980A (en) Traditional Chinese medicine composition for treatment of yin deficiency and yang excess
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN103721237A (en) Traditional Chinese medicine composition for treating hypomenorrhea
CN104225163A (en) Drug composition for treating aplastic anemia and preparation method and application thereof
CN104147490A (en) Traditional Chinese medicine composition beneficial to fetus protection of livestock
CN104474524A (en) Traditional Chinese medicine composition for treating viral myocarditis
CN104399036A (en) Medicine composition for treating chronic diarrhea and application of medicine composition
CN103550642A (en) Traditional Chinese medicine composition for treating wind-warm lung-heat disease caused by wind-heat affecting lung
CN103800859A (en) Traditional Chinese medicinal composition for treating stomach cold

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141203

Termination date: 20151216

EXPY Termination of patent right or utility model